Table 1

Clinical characteristics of SLE patients and healthy controls
Clinical profiles SLE (n = 129) Healthy controls (n = 100)
Sex (male/female) 4/125 26/74
Age in years (mean ± SD) 28.14 ± 8.43 31.18 ± 5.32
Duration of disease years (mean ± SD) 2.90 ± 2.66 -
SLEDAI scores (mean ± SD) 18.36 ± 6.73 -
Photosensitivity rash 34 (26) -
Malar rash 73 (57) -
Discoid rash 14 (11) -
Oral ulcer 76 (59) -
Arthritis 77 (60) -
NPSLE 11 (9) -
Myocarditis 3 (2) -
Serositis 7 (5) -
Nephritis 46 (37) -
Vasculitis 17 (13) -
Treatment details of patients under therapy at the time of recruitment to the study (n = 50)
Medicine Quantity Number of patient treated (%)
Prednisolone; mean (range) 18.99 mg (5-50 mg) 50 (100)
Hydroxychloroquine 6.5 mg/kg body weight 50 (100)
Calcium 1 g/day 50 (100)
Vitamin D3 250-500 IU/day 50 (100)
Azathioprine 50-100 mg/day 4 (8)
Mycophenolate mofetil 2 gm/day 4 (8)

Note: data are number (%) of participants unless otherwise specified. SLE, systemic lupus erythematosus; SLEDAI, SLE disease activity index; NPSLE, neuropsychiatric systemic lupus erythematosus.

Mandal et al.

Mandal et al. Arthritis Research & Therapy 2014 16:R49   doi:10.1186/ar4479

Open Data